Share Email Print
cover

Proceedings Paper

Development of an autofluorescent probe for brain cancer: probe characterization thanks to phantom studies
Author(s): B. Leh; Y. Charon; M.-A. Duval; F. Lefebvre; S. Linden; L. Menard; R. Siebert
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Glioblastoma are brain tumors currently incurable, however, optimized treatment gives better prognosis and quality of life. In case of surgical treatment, there is still need to help surgeons to determine whether a tissue is tumorous or not. Within the framework of the design of a new autofluorescence probe for this issue, optically calibrated gel phantoms have been developed using "tumorous" inclusions in a "healthy" environment. Depending on "tumor" shape, size and localization, the sensitivity of the probe is evaluated. The probe sensitivity for fluorescence spectroscopy will be presented. The probe configuration is also taken into account and compared to simulated results.

Paper Details

Date Published: 25 February 2010
PDF: 6 pages
Proc. SPIE 7567, Design and Performance Validation of Phantoms Used in Conjunction with Optical Measurement of Tissue II, 756707 (25 February 2010); doi: 10.1117/12.841371
Show Author Affiliations
B. Leh, Lab. IMNC, CNRS, Univ. Paris-Sud 11 (France)
Y. Charon, Lab. IMNC, CNRS, Univ. Paris-Sud 11 (France)
Univ. Paris 7 (France)
M.-A. Duval, Lab. IMNC, CNRS, Univ. Paris-Sud 11 (France)
Univ. d'Evry (France)
F. Lefebvre, Lab. IMNC, CNRS, Univ. Paris-Sud 11 (France)
S. Linden, Lab. IMNC, CNRS, Univ. Paris-Sud 11 (United States)
L. Menard, Lab. IMNC, CNRS, Univ. Paris-Sud 11 (France)
Univ. Paris 7 (France)
R. Siebert, Lab. IMNC, CNRS, Univ. Paris-Sud 11 (France)


Published in SPIE Proceedings Vol. 7567:
Design and Performance Validation of Phantoms Used in Conjunction with Optical Measurement of Tissue II
Robert J. Nordstrom, Editor(s)

© SPIE. Terms of Use
Back to Top